In fact, across several experimental approaches, different tissue-specific expression of Tax has not been associated with the onset of an ATLL-like disease but rather a spectrum of other tumors, both epithelial and hematopoietic, including mesenchymal tumors emerging after Tax expression under the control of the CD3-ε promoter [63]. The gene discussed is CNTN2; the disease is mesenchymal cell neoplasm.